The specific primary antibodies were shown in Table 2
CN, CI vs
There are a number of problems with this however
Take photographs in consistent lighting
doi: 10.2147/ijn.s273713 Summary Keywords immunosuppression, immunotherapy resistance, nanomedicine delivery systems, osteosarcoma, translational oncology, tumor microenvironment (TME) Citation Huang Q, Yu G, Shi B and Deng T (2026) Engineering immunity in osteosarcoma: nanomedicine strategies for overcoming immune evasion
Additionally, in the United States, the Food and Drug Administration (FDA) doesnt regulate supplements in the same way as it regulates prescription drugs, and most claims on supplement efficacy are not supported by evidence